Diabetic foot ulcer
Successful treatment with Safetac technology
The benefits of using dressings with Safetac technology in the management of diabetic foot ulcers is explained below. Using a number of different dressings with Safetac technology, these were evaluated in a series of case studies of seven patients with diabetic foot ulcers. Mepilex Lite, Mepilex Heel, Mepilex, Mepilex Border Lite, Mepitel, Mepilex Transfer and Mepilex Ag were selected according to the different treatment requirements of each wound. In each case the dressings with Safetac technology were found to overcome the clinical challenges of these difficult wounds and assisted in the wound healing.
In a non-comparative, observational study evaluating the efficacy and safety of Mepilex Ag in the management of diabetic foot ulcers and the post-operative treatment of diabetic foot associated osteomyelitis, the silver containing dressing was found to be easy to use, malleable, adaptable, and suitable for applying anywhere on the foot. In some cases, Mepilex Ag aided with the pressure off-loading. A favourable healing response was reported for 10/12 wounds (i.e. mean healing time of 57.4 days).
No adverse events were reported. The authors discuss the importance of selecting a dressing as an adjuvant to the treatment of infection that maintains a moist wound environment, allows control of exudate to avoid maceration of the peri-wound region, allows the exchange of gases, isolates the wound, provides comfort for the patient, minimises pain, can be easily removed in order not to damage granulation tissue and peri-lesional skin, and is cost-effective. Based on their accumulated experience, the authors state that Mepilex Ag meets all of these requirements.
New: Addressing local wound infection with a silvercontaining, soft-silcone foam dressing
The results of this study suggest that the signs and symptoms of local wound infection in DFUs can be efficiently resolved via the use of Mepilex Ag, in combination with proper wound care strategies and, where necessary, systemic antibiotics.
Read the complete study.
New: Experiences of Diabetic Foot Ulcers - Perspectives of patients and healthcare professionals
This study aimed to look at the experiences of patients with Diabetic Foot Ulcers (DFU) and to the views of health professionals, or ‘clinicians’. Exploring patient and clinician perspectives helps us to consider ways in which DFU care can be improved.
What were the findings?
Click here to find out!